Celera sales and marketing update

Celera disclosed in its 2Q10 earnings that in July its Berkeley HeartLab Inc. subsidiary launched a test in the U.S. to identify carriers of genetic variants of the Cytochrome P450 2C19 (CYP2C19) gen...